Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine with AraC and Idarubicin in AML and MDS
NCT00838240Phase 2Unknown
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Nov 2008
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 5
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by European Organisation for Research and Treatment of Cancer. Status: unknown.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00838240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00838240.